Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13068931 | 0.83 | GPR84 (0.38) | GPR84PTPN1RIPK1 | |
| SCHEMBL29629074 | 0.83 | GPR84 (0.38) | GPR84PTPN1RIPK1 | |
| SCHEMBL20017710 | 0.79 | GPR84 (0.33) | GPR84 | |
| SCHEMBL1967720 | 0.78 | RIPK1 (0.42) | GPR84RIPK1 | |
| SCHEMBL15286871 | 0.77 | FFAR1 (0.45) | — | |
| SCHEMBL17006161 | 0.77 | ERN1 (0.41) | RIPK1 | |
| SCHEMBL28540474 | 0.76 | GPR84 (0.39) | GPR84 | |
| SCHEMBL28816037 | 0.74 | GPR84 (0.38) | GPR84 | |
| SCHEMBL15286872 | 0.72 | EGFR (0.38) | — | |
| SCHEMBL25327645 | 0.71 | TDP1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | GPR84 86/4885PTPN1 1232/4885RIPK1 3681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.